# Adapalene-Benzoy Peroxide (BPO) Gel in the Treatment of Acne Vulgaris as a 6-month Maintenance

> **NCT00687908** · PHASE3 · COMPLETED · sponsor: **Galderma R&D** · enrollment: 243 (actual)

## Conditions studied

- Acne

## Interventions

- **DRUG:** Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel
- **DRUG:** Vehicle Gel

## Key facts

- **NCT ID:** NCT00687908
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 243 (ACTUAL)
- **Last updated:** 2021-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00687908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00687908, "Adapalene-Benzoy Peroxide (BPO) Gel in the Treatment of Acne Vulgaris as a 6-month Maintenance". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00687908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*